Mission
To deliver functional predictive assays of patient responses to oncology therapeutics
- Company foundation based on extensive research and translational studies at Dana-Farber
- Patented technology from Dana-Farber & MIT
Exclusively licensed to Xsphera Biosciences - Founded in 2018
Early-stage venture backing - Primary focus on drug development platform
Ultimately also enabling functional precision medicine - Deep commitment to IP and human capital
Building a leading research & development team
